This is one of the first longevity transactions to be completed in continental Europe and confirms SCOR’s pioneering role in this emerging and important market.
1770
-
documentDecember 4, 2013 — 00:00
-
Press Releases
Standard & Poor’s has raised the outlook on the “A+” rating of SCOR SE and its main subsidiaries to “positive” as, according to S&P’s statement, “capital and earnings expected to rise due to very strong ERM”.
-
documentNovember 19, 2013 — 00:00
The aims of this brochure are to provide the reader with a simple introduction to genes and genetic processes in humans and an insight as to how this rapidly developing field of science could impact on the insurance i
-
documentNovember 19, 2013 — 00:00
The aims of this brochure are to provide the reader with a simple introduction to genes and genetic processes in humans and an insight as to how this rapidly developing field of science could impact on the insurance i
-
documentNovember 19, 2013 — 00:00
The aims of this brochure are to provide the reader with a simple introduction to genes and genetic processes in humans and an insight as to how this rapidly developing field of science could impact on the insurance i
-
documentNovember 18, 2013 — 00:00
Winner of the Actuarial Award in Germany, 2013
-
documentNovember 18, 2013 — 00:00
Winner of the Actuarial Award in Germany, 2013
-
Press Releases
SCOR's results for the first nine months of 2013.
-
documentNovember 6, 2013 — 00:00
SCOR delivers a strong performance for the first nine months of 2013, recording net income of EUR 302 million
-
documentNovember 6, 2013 — 00:00
SCOR delivers a strong performance for the first nine months of 2013, recording net income of EUR 302 million.
-
documentNovember 6, 2013 — 00:00
SCOR delivers a strong performance for the first nine months of 2013, recording net income of EUR 302 million.
-
documentOctober 14, 2013 — 00:00
Winner of the Actuarial Award in Italy, 2013
Pagination